Østfold Hospital Trust, Sykehuset Østfold HF, postboks 300, 1714, Grålum, Norway.
Faculty of Medicine, University of Oslo, Oslo, Norway.
BMC Geriatr. 2021 Sep 16;21(1):496. doi: 10.1186/s12877-021-02437-x.
In this longitudinal study, we describe how psychotropic drugs (PTDs) are prescribed in nursing home (NH) patients from admission and over a 3-year period, to understand which clinical and environmental factors are associated with PTD prescription.
We used data from the Resource Use and Disease Course in Dementia - Nursing Home (REDIC-NH) study, examining physical and mental health, dementia, and PTD prescription during a 3-year period from admission to a NH. Data were collected every six months. At baseline, we included 696 participants from 47 Norwegian NHs. We presented prevalence, incidence, and deprescribing rates of PTD prescriptions for each assessment point. We calculated the odds of receiving PTDs and used a generalized linear mixed model to analyze the variables associated with a change in odds throughout the 3-year period.
PTD prescriptions were frequent throughout the 3-year period. Antidepressants had the highest prescription rates (28.4%-42.2%). Every PTD category had the highest incidence rate between admission and six months, and antipsychotics had the highest values (49.4%). Deprescribing rates were comparable between assessment points. The odds of antipsychotic prescriptions were lower for older people (OR = 0.96, 95%CI:0.92-0.99, p = 0.023). People with more severe dementia had lower odds of being prescribed sedatives/hypnotics (OR = 0.89, 95%CI:0.85-0.94, p < 0.001).
PTDs, particularly antidepressants, are widely prescribed over time to NH patients. Older patients are less likely to receive antipsychotics. A higher severity of dementia decreases the odds of being prescribed sedatives/hypnotics. Close attention should be paid to PTD prescriptions during long-term NH stay to avoid prolonged and excessive treatment with these types of drugs.
ClinicalTrials.gov Identifier: NCT01920100 .
在这项纵向研究中,我们描述了精神药物(PTDs)在入住养老院(NH)患者中的处方情况,并持续 3 年,以了解哪些临床和环境因素与 PTD 处方有关。
我们使用了来自资源使用和疾病过程在痴呆症-养老院(REDIC-NH)研究的数据,在 NH 入住后的 3 年期间检查了身体和心理健康、痴呆症和 PTD 处方情况。数据每 6 个月收集一次。在基线时,我们纳入了来自挪威 47 家 NH 的 696 名参与者。我们介绍了每个评估点的 PTD 处方的患病率、发病率和去处方率。我们计算了接受 PTD 的可能性,并使用广义线性混合模型分析了整个 3 年期间与可能性变化相关的变量。
PTD 处方在整个 3 年期间都很常见。抗抑郁药的处方率最高(28.4%-42.2%)。每个 PTD 类别在入住和 6 个月之间的发病率最高,抗精神病药的发病率最高(49.4%)。各评估点之间的去处方率相当。年龄较大的人接受抗精神病药处方的可能性较低(OR=0.96,95%CI:0.92-0.99,p=0.023)。痴呆症更严重的人被开镇静/催眠药的可能性较低(OR=0.89,95%CI:0.85-0.94,p<0.001)。
随着时间的推移,NH 患者广泛使用 PTD,特别是抗抑郁药。年龄较大的患者不太可能接受抗精神病药。痴呆症的严重程度降低了开镇静/催眠药的可能性。在 NH 长期入住期间应密切关注 PTD 处方,以避免长期和过度使用此类药物。
ClinicalTrials.gov 标识符:NCT01920100。